Search details
1.
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis.
Eur Respir J
; 61(3)2023 03.
Article
in English
| MEDLINE | ID: mdl-36328357
2.
Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis.
Antimicrob Agents Chemother
; 66(6): e0226421, 2022 06 21.
Article
in English
| MEDLINE | ID: mdl-35506699
3.
Anton Ghon and His Colleagues and Their Studies of the Primary Focus and Complex of Tuberculosis Infection and Their Relevance for the Twenty-First Century.
Respiration
; 100(7): 557-567, 2021.
Article
in English
| MEDLINE | ID: mdl-33321506
4.
The pharmacokinetics of para-aminosalicylic acid and its relationship to efficacy and intolerance.
Br J Clin Pharmacol
; 86(11): 2123-2132, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32470182
5.
Probability of mycobactericidal activity of para-aminosalicylic acid with novel dosing regimens.
Eur J Clin Pharmacol
; 76(11): 1557-1565, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-32588106
6.
Erratum for van der Laan et al., "Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis".
Antimicrob Agents Chemother
; 67(7): e0072023, 2023 07 18.
Article
in English
| MEDLINE | ID: mdl-37338349
7.
Time Trends in Sputum Mycobacterial Load and Two-Day Bactericidal Activity of Isoniazid-Containing Antituberculosis Therapies.
Antimicrob Agents Chemother
; 61(4)2017 04.
Article
in English
| MEDLINE | ID: mdl-28137798
8.
Revisiting the mutant prevention concentration to guide dosing in childhood tuberculosis.
J Antimicrob Chemother
; 72(7): 1848-1857, 2017 07 01.
Article
in English
| MEDLINE | ID: mdl-28333284
9.
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis.
Lancet
; 385(9979): 1738-1747, 2015 May 02.
Article
in English
| MEDLINE | ID: mdl-25795076
10.
Bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquiline.
Am J Respir Crit Care Med
; 191(8): 943-53, 2015 Apr 15.
Article
in English
| MEDLINE | ID: mdl-25622149
11.
Extensive pulmonary and extrapulmonary tuberculosis in a child presenting with a chest wall abscess: The value of different modes of imaging.
J Paediatr Child Health
; 57(7): 1105-1108, 2021 07.
Article
in English
| MEDLINE | ID: mdl-32865847
12.
N-acetyltransferase genotypes and the pharmacokinetics and tolerability of para-aminosalicylic acid in patients with drug-resistant pulmonary tuberculosis.
Antimicrob Agents Chemother
; 59(7): 4129-38, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25963985
13.
Uniform research case definition criteria differentiate tuberculous and bacterial meningitis in children.
Clin Infect Dis
; 59(11): 1574-8, 2014 Dec 01.
Article
in English
| MEDLINE | ID: mdl-25139968
14.
Pharmacokinetics of para-aminosalicylic acid in HIV-uninfected and HIV-coinfected tuberculosis patients receiving antiretroviral therapy, managed for multidrug-resistant and extensively drug-resistant tuberculosis.
Antimicrob Agents Chemother
; 58(10): 6242-50, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-25114132
15.
Chemotherapy for Tuberculous Meningitis.
N Engl J Med
; 374(2): 179-81, 2016 Jan 14.
Article
in English
| MEDLINE | ID: mdl-26760090
16.
Population pharmacokinetics of rifampicin, pyrazinamide and isoniazid in children with tuberculosis: in silico evaluation of currently recommended doses.
J Antimicrob Chemother
; 69(5): 1339-49, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24486870
17.
Randomized dose-ranging study of the 14-day early bactericidal activity of bedaquiline (TMC207) in patients with sputum microscopy smear-positive pulmonary tuberculosis.
Antimicrob Agents Chemother
; 57(5): 2199-203, 2013 May.
Article
in English
| MEDLINE | ID: mdl-23459487
18.
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial.
Lancet
; 380(9846): 986-93, 2012 Sep 15.
Article
in English
| MEDLINE | ID: mdl-22828481
19.
Culture-confirmed multidrug-resistant tuberculosis in children: clinical features, treatment, and outcome.
Clin Infect Dis
; 54(2): 157-66, 2012 Jan 15.
Article
in English
| MEDLINE | ID: mdl-22052896
20.
Phase II dose-ranging trial of the early bactericidal activity of PA-824.
Antimicrob Agents Chemother
; 56(6): 3027-31, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22430968